BioTissue Stock

Aspect Biosystems and Novo Nordisk are collaborating on a $2.6 billion project to develop therapeutics for type 1 diabetes and obesity. The companies aim to create 3D, biologically functional tissues containing insulin-producing cells that can be implanted without the need for immunosuppressive drugs. The partnership will fund up to four products for the treatment of diabetes and/or obesity, with Aspect eligible to receive up to $650 million per project based on future milestones, plus royalties on product sales.

Newcastle-based 3D Bio-Tissues (3DBT) has produced the world's first 100% cultivated pork steak, which replicates the flavour and texture of traditional pork. The meat was made using 3DBT's patented, serum-free and animal-free cell booster, City-mixTM. 3DBT, owned by BSF Enterprise plc, plans to produce a full-scale fillet of cultivated pork and work with manufacturers and supermarkets to distribute the product.